Mackenzie Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.9M | Buy |
|
|||||
|
2025
Q2 | $9.52M | Sell |
|
|||||
|
2025
Q1 | $9.52M | Buy |
|
|||||
|
2024
Q4 | $7.54M | Sell |
|
|||||
|
2024
Q3 | $9.98M | Sell |
|
|||||
|
2024
Q2 | $12.2M | Sell |
|
|||||
|
2024
Q1 | $12.7M | Sell |
|
|||||
|
2023
Q4 | $12.8M | Buy |
|
|||||
|
2023
Q3 | $10.6M | Buy |
|
|||||
|
2023
Q2 | $8.73M | Buy |
|
|||||
|
2023
Q1 | $4.89M | Buy |
|
|||||
|
2022
Q4 | $4.71M | Buy |
|
|||||
|
2022
Q3 | $3.77M | Sell |
|
|||||
|
2022
Q2 | $4.21M | Buy |
|
|||||
|
2022
Q1 | $2.8M | Buy |
|
|||||
|
2021
Q4 | $868K | Sell |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $945K | Sell |
|
|||||
|
2021
Q1 | $957K | Sell |
|
|||||
|
2020
Q4 | $1.65M | Buy |
|
|||||
|
2020
Q3 | $1.57M | Buy |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | $652K | Sell |
|
|||||
|
2019
Q4 | $815K | Sell |
|
|||||
|
2019
Q3 | $795K | Buy |
|
|||||
|
2019
Q2 | $612K | Sell |
|
|||||
|
2019
Q1 | $766K | Buy |
|
|||||
|
2018
Q4 | $533K | Buy |
|
|||||
|
2018
Q3 | $711K | Buy |
|
|||||
|
2018
Q2 | $278K | Sell |
|
|||||
|
2018
Q1 | $295K | Buy |
|